Citigroup’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-20,687
Closed -$851K 7742
2020
Q1
$851K Buy
+20,687
New +$991K ﹤0.01% 3359

Other funds holding ELAT

Citigroup's ELAT Position: Q2 2020 in Review

Citigroup sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q2 2020, closing a stake of 20,687 shares — an estimated $851K sold.

Citigroup first reported a position in ELAT in Q1 2020 and held it in 1 quarter. The position peaked at $851K in Q1 2020. 29 funds tracked by Wall St. Rank hold ELAT as of Q2 2020.

  • Citigroup reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q2 2020 after selling out during the quarter.
  • Citigroup sold 20,687 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q2 2020, an estimated $851K.
  • Citigroup first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 1 quarter.
  • Citigroup's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $851K in Q1 2020.
  • 29 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q2 2020.

Based on Citigroup's 13F filing for Q2 2020, filed 12 Aug 2020.